| scholarly article | Q13442814 |
| P50 | author | David K. Crossman | Q42773739 |
| Joseph G Pressey | Q56073231 | ||
| Frederic G. Barr | Q112547144 | ||
| James R. Anderson | Q112547434 | ||
| P2093 | author name string | James C Lynch | |
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. | Q27851485 | ||
| Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours | Q28206040 | ||
| Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation | Q28207216 | ||
| Hedgehog signaling in animal development: paradigms and principles | Q28208463 | ||
| Prediction of central nervous system embryonal tumour outcome based on gene expression | Q29618619 | ||
| Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease | Q33951643 | ||
| Inhibition of the hedgehog pathway in advanced basal-cell carcinoma | Q34019208 | ||
| Evaluation of survival data and two new rank order statistics arising in its consideration | Q34054360 | ||
| Mutations in SUFU predispose to medulloblastoma | Q34133729 | ||
| Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists | Q35785923 | ||
| Paracrine Hedgehog signaling in cancer | Q37564811 | ||
| GDC-0449--targeting the hedgehog signaling pathway | Q37674252 | ||
| Nevoid basal-cell carcinoma syndrome | Q39759038 | ||
| The EWS/FLI1 oncogenic transcription factor deregulates GLI1. | Q40034798 | ||
| The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A | Q40677917 | ||
| The Gorlin syndrome gene: a tumor suppressor active in basal cell carcinogenesis and embryonic development. | Q40983924 | ||
| Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 | Q42031842 | ||
| Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome | Q42455110 | ||
| Case report: nasopharyngeal rhabdomyosarcoma and Gorlin's naevoid basal cell carcinoma syndrome | Q42465028 | ||
| A frequent activated smoothened mutation in sporadic basal cell carcinomas | Q42467910 | ||
| Hedgehog controls neural stem cells through p53-independent regulation of Nanog | Q42474956 | ||
| Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development | Q42486654 | ||
| Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma | Q57243407 | ||
| Undifferentiated sarcomas of children: pathology and clinical behavior--an Intergroup Rhabdomyosarcoma study | Q73488000 | ||
| Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study | Q73553819 | ||
| Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes | Q77538121 | ||
| P433 | issue | 6 | |
| P921 | main subject | embryonal rhabdomyosarcoma | Q5370233 |
| P304 | page(s) | 930-938 | |
| P577 | publication date | 2011-05-25 | |
| P1433 | published in | Pediatric Blood & Cancer | Q15754342 |
| P1476 | title | Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group | |
| P478 | volume | 57 |
| Q36343292 | A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. |
| Q55265062 | A review of soft-tissue sarcomas: translation of biological advances into treatment measures. |
| Q52649683 | Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors. |
| Q36030949 | CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV |
| Q41847776 | Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma |
| Q50027091 | Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group |
| Q48138311 | Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations. |
| Q92542126 | Current and Future Treatment Strategies for Rhabdomyosarcoma |
| Q57492122 | Different Response of Mutant and Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors |
| Q30426842 | Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting |
| Q38820614 | FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target |
| Q35067950 | GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis |
| Q44315676 | Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction |
| Q40803127 | Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines |
| Q50116993 | Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. |
| Q38834036 | Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells |
| Q38902471 | Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma |
| Q47841646 | Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands. |
| Q92293214 | Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma |
| Q34267924 | New therapeutic targets in soft tissue sarcoma |
| Q26783611 | Non-Canonical Hh Signaling in Cancer-Current Understanding and Future Directions |
| Q42153919 | Notch, wnt, and hedgehog pathways in rhabdomyosarcoma: from single pathways to an integrated network |
| Q36142754 | Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems. |
| Q36602649 | Prognostic role of Gli1 expression in solid malignancies: a meta-analysis |
| Q38105879 | Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. |
| Q57962903 | Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer |
| Q37232227 | Targeting hedgehog signaling in cancer: research and clinical developments |
| Q38802190 | Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors |
| Q33586736 | Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma |
| Q36240079 | The Hedgehog pathway: role in cell differentiation, polarity and proliferation |
| Q38050831 | What is new in rhabdomyosarcoma management in children? |
| Q33895506 | What is new in the biology and treatment of pediatric rhabdomyosarcoma? |
Search more.